New Analysis Framework Incorporating Mixed Mutual Information and Scalable Bayesian Networks for Multimodal High Dimensional Genomic and Epigenomic Cancer Data

Abstract

We propose a novel two-stage analysis strategy to discover candidate genes associated with the particular cancer outcomes in large multimodal genomic cancers databases, such as The Cancer Genome Atlas (TCGA). During the first stage, we use mixed mutual information to perform variable selection; during the second stage, we use scalable Bayesian network (BN) modeling to identify candidate genes and their interactions. Two crucial features of the proposed approach are (i) the ability to handle mixed data types (continuous and discrete, genomic, epigenomic, etc.) and (ii) a flexible boundary between the variable selection and network modeling stages-the boundary that can be adjusted in accordance with the investigators' BN software scalability and hardware implementation. These two aspects result in high generalizability of the proposed analytical framework. We apply the above strategy to three different TCGA datasets (LGG, Brain Lower Grade Glioma; HNSC, Head and Neck Squamous Cell Carcinoma; STES, Stomach and Esophageal Carcinoma), linking multimodal molecular information (SNPs, mRNA expression, DNA methylation) to two clinical outcome variables (tumor status and patient survival). We identify 11 candidate genes, of which 6 have already been directly implicated in the cancer literature. One novel LGG prognostic factor suggested by our analysis, methylation of TMPRSS11F type II transmembrane serine protease, presents intriguing direction for the follow-up studies.

Data Harmonization for Heterogeneous Datasets: A Systematic Literature Review

“…With the advent of technology and tools, multimodalities were used by various researchers for big multimodal data by using text, audio, visual, and physiological signals [27]. The replacement of the data harmonization keyword was proposed, such as data integration and fusion [95]. A survey paper has been published that deals with affective computing [26] and related areas, such as opinion mining, emotion, and sentiment analysis.…”

Dissecting Response to Cancer Immunotherapy by Applying Bayesian Network Analysis to Flow Cytometry Data

“…The numbers next to the edges and edge “thickness” in the resulting BN figures specify the relative edge strengths (which are marginal likelihood-based). Further details on the BN modeling in general and our implementation thereof can be found in [ 37 , 39 ].…”

Integration of artificial intelligence in lung cancer: Rise of the machine

“…These include “simple” decision trees, regression models such as least absolute shrinkage and selection operator (LASSO), and Bayesian probabilistic causal networks, though these are not applicable to all clinical problems/models. 89 , 90 , 91 , 92 , 93 , 94 , 95 …”